Clinical practice guidelines for the use of recombinant and plasma-derived factor VIII and factor IX products

View publication

Collection

MeSH Terms

Factor XI Deficiency (C15.378.100.100.325); Factor X Deficiency (C15.378.100.100.320); Factor VII Deficiency (C15.378.100.100.310); Factor V Deficiency (C15.378.100.100.300); von Willebrand Diseases (C15.378.100.100.900); Blood Coagulation Disorders; Inherited (C15.378.100.100); Hemophilia B (C15.378.100.100.510); Hemophilia A (C15.378.100.100.500); Factor XIII Deficiency (C15.378.100.100.335); Factor XII Deficiency (C15.378.100.100.330)

Record Publish Year

2020

Guideline Contact

Skye Newton (skye.newton@adelaide.edu.au)

Publication Scope

management

Countries of Application

Australia

Guideline Publication Status

Published

Languages

English

Authors

AHTA (AU)

Publication Year

2005